MedPath
NMPA Approval

Peramivir Injection

国药准字H20243853

May 28, 2024

Drug Information

帕拉米韦注射液

注射剂

60ml:0.3g(按C₁₅H₂₈N₄O₄计)

化学药品

May 28, 2024

Company Information

Applicant Company

浙江省新昌县城关镇环城东路59号

Manufacturing Company

绍兴市新昌县城关镇新昌大道东路98号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

帕拉米韦注射液 - NMPA 批准文号 | MedPath